# Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer

> **NCT00072098** · PHASE1 · TERMINATED · sponsor: **Max Sung** · enrollment: 22 (actual)

## Conditions studied

- Colorectal Cancer
- Metastatic Cancer

## Interventions

- **BIOLOGICAL:** adenovirus vector
- **BIOLOGICAL:** interleukin-12 gene

## Key facts

- **NCT ID:** NCT00072098
- **Lead sponsor:** Max Sung
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-09
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** limited funding
- **Last updated:** 2017-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00072098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00072098, "Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00072098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*